Eugene

[email protected]

LATEST

Seattle Genetics To Acquire Biopharm Company Cascadian Therapeutics for $614 Million
By

By
Seattle Genetics, a Bothell, Washington-headquartered biopharmaceutical company, has agreed to acquire Cascadian Therapeutics, a Seattle, Washington-headquartered biopharmaceutical company focused on oncology, for $614 million. Cascadian Therapeutics’ most advanced program is…

Avacta Partners in Gene Therapy Pact
By

By
Avacta Group, a Cambridge, UK-based life-sciences tool company that provides instrumentation, consumables, and research reagents, has signed a research pact with OncoSec Medical, a San Diego, California-headquartered company developing intratumoral…

Hovione Brings On Line Capsule-Filling Unit
By

By
Hovione, a contract development and manufacturing organization, reports that its MG2 Tekna Precision capsule-filling unit is on line in its Portugal facilities. The new unit adds to Hovione’s services in…

Pall Launches New Biotech Business Unit
By

By
Pall Corporation, a provider of filtration, separation and purification products and services, has named a new business unit, Pall Biotech, within the Pall Life Sciences Division to focus on end-to-end…

Cambrex To Expand Chemical and Analytical Capabilities
By

By
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has announced an investment to expand chemical and analytical development capabilities at its Charles City, Iowa…

Almac Appoints Head of Biocatalysis
By

By
Almac Group, a Craigavon, UK-based contract development and manufacturing organization, has appointed Stefan Mix, PhD, as head of biocatalysis, effective January 2, 2018. Mix joined the Almac Sciences business in…

Almac Invests in Elemental Impurities Lab
By

By
Almac Group, a Craigavon, UK-based contract development and manufacturing organization, has invested in an elemental impurities analysis laboratory at its European headquarters in Craigavon. The new temperature-controlled laboratory will incorporate…

Porton, BioDuro Partner
By

By
BioDuro, a San Diego, California-headquartered a contract research, development and manufacturing organization, has signed a pact with Porton Pharma Solutions, a Chongqing, China-based provider of active pharmaceutical ingredient (API) development…

SK biotek Sets Up Operations at API Mfg Facility in Ireland
By

By
SK biotek, a Seoul, South Korea-based wholly owned subsidiary of SK Holdings, has set up operations at its active pharmaceutical ingredients (API) facility in Dublin, Ireland, according to IDA Ireland,…

Merck KGaA, Juniper Expand Supply Pact
By

By
Merck KGaA and Juniper Pharmaceuticals, a Boston, Massachusetts-headquartered specialty pharmaceutical company with contract development and manufacturing services, have extended a supply agreement for Crinone (progesterone gel), Juniper’s bioadhesive vaginal gel…